MoneyWorks4Me

Natural Capsules Ltd (NATCAPSUQ)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524654 NSE: NATCAPSUQ Pharmaceuticals & Drugs | Small Cap | Natural Capsules Share Price

₹170.25 -2.60 (-1.50%)

As on 23-Sep'26 11:42

Natural Capsules Ltd (NATCAPSUQ)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524654 NSE: NATCAPSUQ Pharmaceuticals & Drugs | Small Cap | Natural Capsules Share Price

₹170.25 -2.60 (-1.50%)

As on 23-Sep'26 11:42

Key Metrics
Valuation Multiples
Market Cap
₹180 Cr.
Current Price
₹170.3
52-Week Low / High
₹138 / 296
TTM EPS
₹-20.7
TTM Sales
₹191 Cr.
Book Value per Share
₹206.2
P/E Ratio
0.00
Lower than its 5-year historical median
Industry PE
54.8
Price to Book (P/B)
0.84
Lower than its 5-year historical median
Price to Sales (P/S)
0.94
Lower than its 5-year historical median
EV/EBITDA
97.56
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
-10.89%
Underperforms industry median
Return on Capital Employed (ROCE)
-4.85%
Underperforms industry median
Return on Assets (ROA)
-5.87%
Operating Profit Margin
-1.4%
Net Profit Margin
-13.17%
Gross Profit Margin
-5.8%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
3.47%
Operating Profit Growth (1 Year)
-
-114.64%
Net Profit Growth (1 Year)
-
-4077.42%
Asset Quality
Promoter Holding
50.92%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹204 Cr.
Equity
₹10.4 Cr.
Face Value
₹10
All Time Low / High
₹0.08 / 679.00

Natural Capsules stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Somewhat Undervalued

Price Trend

Semi Strong
Q.1 Is Natural Capsules Ltd a good quality company?
Natural Capsules Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Natural Capsules Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Natural Capsules Ltd vs industry peers?
Natural Capsules Ltd revenue CAGR is 18.68%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Natural Capsules Ltd?
Promoters hold 50.92% of the Natural Capsules Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Natural Capsules Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 9.2% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Natural Capsules Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % 1.8%3.6%4.5%3.7%14.6%22.9%20.5%8.4%7.4%9.3%-
Value Creation
Index
-0.9-0.7-0.7-0.70.00.60.5-0.4-0.5-0.3-

Growth Parameters

Sales 53.654.859.861.679.5135173154168174173
Sales YoY Gr.-2.1%9.2%3%29.2%69.9%28%-11%9.2%3.5%-
Adj EPS 1.41.32.30.77.214.719.77.56.49.212.2
YoY Gr.--1.5%75.2%-72.1%1006.2%104.7%33.9%-61.9%-15.2%44.6%-
BVPS (₹) 7171.57373.281.7118.5133.7141.2160.4171.9175.4
Adj Net
Profit
111.80.55.513.818.476.69.613
Cash Flow from Ops. 1.95.42.17.25.85.120.15.41836.2-
Debt/CF from Ops. 1.602.60.91.76.42.511.53.11.6-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 14%16.9%0.2%3.5%
Adj EPS 23.8%5.1%-22.4%44.6%
BVPS10.3%16%8.7%7.1%
Share Price 9% 5.5% -24.5% -24.4%

Key Financial Parameters

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity %
1.91.93.20.99.31917.85.54.45.57
Op. Profit
Mgn %
9.610.18.58.914.518.120.112.511.511.213.4
Net Profit
Mgn %
1.91.930.86.910.210.74.63.95.57.4
Debt to
Equity
0.100.10.10.20.40.40.50.30.3-
Working Cap
Days
27827325324623118218123928635489
Cash Conv.
Cycle
1791721611659731428390816

Valuation of Natural Capsules - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Sales55606280135172155169187
Operating Expenses + 49555668111138137152190
Manufacturing Costs121514142228303144
Material Costs2426283760797985102
Employee Cost 5667810111319
Other Costs 988102122172324
Operating Profit 6551124341818-3
Operating Profit Margin (%) 10.1%8.5%8.8%14.0%18.0%19.9%11.9%10.4%-1.4%
Other Income + 111122413
Exceptional Items 0-00200000
Interest 0111245712
Depreciation 4344579917
Profit Before Tax 2219192583-28
Tax 10125722-3
Profit After Tax 1217141861-25
PAT Margin (%) 2.0%3.2%1.4%8.7%10.3%10.7%3.6%0.4%-13.2%
Adjusted EPS (₹)1.52.51.19.019.619.96.00.6-23.8
Dividend Payout Ratio (%)56.10%32.50%43.60%9.10%5.10%5%0%0%0%
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 5455566283123204233220
Share Capital 66667991010
Reserves 4849495676114194222210
Debt +0561051929893100
Long Term Debt00003470685655
Short Term Debt056101622303745
Minority Interest0000025252413
Trade Payables1287161627303955
Others Liabilities 54691521193133
Total Liabilities 71737597164289377419422

Fixed Assets

Net Fixed Assets +222424386697103284274
Gross Block61667087112149164354362
Accumulated Depreciation404246494553617088
CWIP 1227208814404
Investments 556000333
Inventories845759192526
Trade Receivables313230272652546271
Cash Equivalents 1112571355
Others Assets 347174236404038
Total Assets 71737597164289377419422
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity + 5276-117-82711
PBT 2219192583-28
Adjustment 5452610141630
Changes in Working Capital -1-31-4-21-13-281012
Tax Paid 0-1-1-2-5-5-2-2-4
Cash Flow From Investing Activity + -1-7-6-9-46-105-73-44-11
Capex -1-7-5-16-46-105-71-45-12
Net Investments 0-0-18-00-300
Others 000000101
Cash Flow From Financing Activity + -44-1348878216-1
Net Proceeds from Shares 000084876280
Net Proceeds from Borrowing 00003436-2-12-2
Interest Paid -0-0-1-0-2-3-5-6-11
Dividend Paid -1-1-1-0-1-1-100
Others -35038815612
Net Cash Flow 0-10-0101-2-0
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)2.053.51.5411.7419.1817.893.40.28-10.89
ROCE (%)3.714.513.7114.5220.7516.1852.87-4.85
Asset Turnover Ratio0.770.830.830.931.030.760.470.430.45
PAT to CFO Conversion(x)5170.86-0.070.94-1.3327N/A
Working Capital Days
Receivable Days208.40193.70185.5013171.6083125.20125.90130.20
Inventory Days51.3036.7028.5027.3015.1014.2032.704850.50
Payable Days184.80139.9099.10112.3097.80100.70134.20148.20167.30

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Natural Capsules Ltd FAQs

The current trading price of Natural Capsules on 23-Sep-2026 11:42 is ₹170.2.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 22-Sep-2026 the market cap of Natural Capsules stood at ₹180.0 Cr

The latest P/E ratio of Natural Capsules as of 22-Sep-2026 is 14.14.

The latest P/B ratio of Natural Capsules as of 22-Sep-2026 is 0.99.

The 52-week high of Natural Capsules is ₹296.4 and the 52-week low is ₹137.5.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Natural Capsules is ₹173 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Natural Capsules Ltd is a below average quality company.

The key valuation ratios of Natural Capsules Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Natural Capsules Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Natural Capsules Ltd

Natural Capsules (NCL) is a trusted name among capsule manufacturers in India, established in 1993 in Bangalore and expanded in 2003 to Pondicherry. The company operates well-equipped, modern manufacturing facilities for producing hard gelatin capsule shells, hard cellulose (HPMC) capsule shells, and pharmaceutical dosage forms in capsule format. As a WHO-GMP and ISO 9001 certified manufacturer of hard gelatin and HPMC capsules shells, it complies with all national and international standards. The company follows best practices in cGMP (current Good Manufacturing Practice) and cGLP (current Good Laboratory Practice). Since inception, Natural Capsules has provided complete capsule manufacturing solutions, constantly improving through innovation, technology, and product excellence.

The main objective of the company is to manufacture and market Hard Gelatin Capsule shells and Hard Cellulose Capsule Shells (both printed and unprinted). These capsules are sold in domestic and also exported to several countries. The logical integration of NCL hard shell manufacturing to formulation was initiated in the year 1998. The company is also engaged in formulating the pharmaceutical dosage forms in Capsule dosage form, both Pharma and Neutraceutical Products. The Pharmaceutical and Dietary supplement industries count on Natural Capsules to supply hard two-piece Gelatin and Cellulose capsules. 

Business Verticals

  • Capsules Vertical: NCL’s capsules business is anchored in a culture of process innovation, operational excellence, and consistent capital investment. The company’s facilities operate with dedicated manufacturing lines that adhere to globally recognised quality standards, including WHO-GMP, ISO 9001:2015, HACCP, and Halal certifications.
  • APIs Vertical: In line with its strategic diversification and value-accretive initiatives, NCL entered the Active Pharmaceutical Ingredients (API) segment with the aim of reducing India’s dependence on imports and becoming a key player in niche therapeutic areas. This facility leverages fermentation-based synthesis from Key Starting Materials (KSMs) and is among the few in India to focus on the production of steroidal APIs.

Business area of the company 

NCL is a respected manufacturer in the pharmaceutical industry, with a strong presence in both capsule and active pharmaceutical ingredient (API) production.

Products 

  • Hard Gelatin Capsule Shells
  • Hard Cellulose Capsule Shells
  • BSE / TSE Free Gelatin Capsule Shells
  • Shiny Gelatin Capsule Shells
  • SLS Free Gelatin Capsule Shells
  • Halal Certified Gelatin Capsule Shells
  • Fast Release Gelatin Capsule Shells
  • Printed Gelatin / Cellulose Capsule Shells
  • Vegetarian Capsule Shells
  • Enteric Capsule Shells

Milestones

Early Success and Expansion

  • Natural Capsules Limited was incorporated in 1993 as a Public Limited Company in Bangalore.
  • Operations commenced in 1995 with three capsule manufacturing lines and an annual capacity of 1.03 billion capsules. 
  • In 2001, the company became the first in India to manufacture vegetarian capsules, marking a significant achievement. 
  • The early 2000s saw rapid expansion, including the acquisition of a Pondicherry unit in 2003.

2005-2007

  • Acquired five lines from IPCL Godhra and installed them in Pondicherry.

2009-2012

  • Acquired nine lines from Qualicaps Canada and installed them in Pondicherry.

2011-2014

  • Upgraded multiple lines, increasing individual capacities from 1 million capsules per day to 1.5 million capsules per day.
  • By 2014, annual installed capacity had reached 7.1 billion capsules per day

From 2019 onwards

  • Natural Capsules experienced renewed growth across both domestic and international markets, resulting in improved margins. 
  • The company maintained its emphasis on technological advancement, systematically enhancing its manufacturing capabilities to support increasing demand and operational efficiency.
  • During this period, a capsule manufacturing line was upgraded to achieve a production rate of 2.5 million capsules per day, up from 1.0 million capsules per day. 
  • The installation of the new generation machine in Bangalore further advanced production, delivering a capacity of 4.8 to 5.0 million capsules per day.
  • As of the end of FY25, the company’s installed capacity stands at 19.50 billion capsules per annum.
  • In a significant step, the Company has expanded into active pharmaceutical ingredient (API) manufacturing through its subsidiary, Natural Biogenex. 

You have 47 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now